Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department's plans to expand the eligibility for antivirals to include patients that remain at moderate to high risk of developing severe covid-19.

The PANORAMIC national study is gathering further evidence on which patients would benefits most from oral antiviral treatments for COVID-19. The results from this study inform clinical policy on access to these treatments through the National Health Service, including any expansion of the eligible patient cohorts.